SECsense Logo

Glucotrack, Inc. 8-K Report: Key Developments as of January 7, 2025

$GCTK
Form 8-K
Filed on: 2025-01-08
Source
Glucotrack, Inc. 8-K Report: Key Developments as of January 7, 2025

Based on the provided excerpt from the financial report, here are the key pieces of information and insights extracted:

  1. Entity Information:
  • Company Name: Glucotrack, Inc.
  • Entity Identifier (CIK): 0001506983
  • State of Incorporation: Delaware (DE)
  • SEC File Number: 001-41141
  • Tax Identification Number (EIN): 98-0668934
  • Address: 301 Rte 17 North Ste. 800, Rutherford, NJ 07070
  • Contact Number: (201) 842-7715
  1. Filing Type:
  • Form Type: 8-K (Current Report)
  1. Filing Date:
  • Date of Filing: January 7, 2025
  1. Stock Information:
  • Common Stock Ticker: GCTK
  • Exchange: NASDAQ
  1. Measurement Units:
  • The financial data is reported in USD (United States Dollars).
  • There are references to shares, indicating the company's common stock is being reported in terms of share count and value.
  1. Context Information:
  • The report is relevant to a specific date, January 7, 2025.
  • The context suggests it may contain information pertinent to events or changes affecting the company as of that date.

Insights:

  • The report indicates that Glucotrack, Inc. is a publicly traded company on NASDAQ, which could imply ongoing regulatory obligations to disclose significant events or changes affecting the company’s financial status.
  • The filing of an 8-K suggests that there may be important developments or announcements that shareholders and potential investors should be aware of as of the filing date.
  • The inclusion of specific identifiers and detailed company information suggests the report is comprehensive and adheres to SEC filing requirements, ensuring transparency for investors.

This analysis can help stakeholders assess the company's current status and any significant events that may impact its operations or stock performance.